Plain-English Summary
Microplastics in atheromas in Patients undergoing carotid endarterectomy with plaque analysis and follow-up. Plastic particles in arterial plaque are a serious human signal.
VV Study Evidence Matrix v1.0
VV Evidence Utility Score
A bounded score for how useful this study is in public explanation, based on evidence tier, design, applicability, endpoint relevance, limitations, safety signals, and publication/source strength.
70/100
Useful Public Evidence
- Evidence tier
- 66/100, weight 18%
- Design strength
- 66/100, weight 18%
- Applicability
- 66/100, weight 16%
- Endpoint relevance
- 88/100, weight 16%
- Limitations transparency
- 60/100, weight 12%
- Safety signal usefulness
- 57/100, weight 10%
- Publication/source strength
- 88/100, weight 10%
Useful for context, but limited by safety signal usefulness, limitations transparency, evidence tier.
How the study framework works ->Key Findings
- Plastic particles in arterial plaque are a serious human signal.
- The association is not the same as individual causality proof.
Limitations
- Observational design cannot prove causality.
- Population had advanced carotid disease requiring surgery.
Why It Matters
Detection of microplastics/nanoplastics in plaque and association with cardiovascular events.
Viral Vitalism Verdict
Useful evidence, bounded by design: Observational design cannot prove causality.
Sources
- Microplastics and nanoplastics in atheromas and cardiovascular events - New England Journal of Medicine
Signal cards
Used in signals
Signal coverage connected to this study through explicit study links, canonical source refs, or evidence visualizations.
Microplastics, BPA, and Phthalates: Endocrine Panic or Real Exposure Signal?
Microplastics, BPA, and phthalates sit between real environmental-health concern and viral endocrine panic. The credible path is to separate exposure, biomonitoring, mechanistic plausibility, fertility signals, cardiovascular findings, and practical reduction from certainty theater.
VV Signal Score
57
Early or context-dependent
- Sources
- 7
- Studies
- 7
- Claims
- 5
Claim ledger
Relevant claims
Claim ledger records connected through this study's ID, topic tags, or source IDs.
semaglutide: Semaglutide reduced major adverse cardiovascular events in SELECT participants
Semaglutide reduced major adverse cardiovascular events in SELECT participants with overweight or obesity and established cardiovascular disease without diabetes.
glp 1: GLP-1-based therapies have demonstrated outcome benefits beyond weight loss
GLP-1-based therapies have demonstrated outcome benefits beyond weight loss in specific high-risk cardiometabolic populations.
vegan diet: Vegetarian and vegan diets can lower LDL-C and apoB
Vegetarian and vegan diets can lower LDL-C and apoB on average in randomized trials, especially when they improve saturated-fat and fiber patterns.
carnivore diet: Strict carnivore and zero-plant eating conflict with current U.S.
Strict carnivore and zero-plant eating conflict with current U.S. dietary guidance emphasizing whole nutrient-dense foods including vegetables, fruits, healthy fats, dairy, protein foods, and whole grains.
sleep: Sleep duration is associated with all-cause mortality in a
Sleep duration is associated with all-cause mortality in a U-shaped pattern in prospective cohort meta-analysis, with both short and long sleep linked to higher mortality risk versus roughly 7 hours, but causality is not proven.
seed oils: The claim that seed oils cause heart disease is
The claim that seed oils cause heart disease is too broad, especially when unsaturated fats replace saturated fats rather than being added through ultra-processed foods.